[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Baumann et al., 2016 - Google Patents

Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells

Baumann et al., 2016

View HTML @Full View
Document ID
4455654668066580830
Author
Baumann J
Wong J
Sun Y
Conklin D
Publication year
Publication venue
BMC cancer

External Links

Snippet

Background HER2/neu-positive breast cancer cells have recently been shown to use a unique Warburg-like metabolism for survival and aggressive behavior. These cells exhibit increased fatty acid synthesis and storage compared to normal breast cells or other tumor …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification

Similar Documents

Publication Publication Date Title
Baumann et al. Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells
Annunziata et al. MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat
Ali et al. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
Baker et al. Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival
Park et al. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment
Lee et al. TRPV4 regulates breast cancer cell extravasation, stiffness and actin cortex
Deblois et al. ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
Ong et al. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents
Yamamoto et al. NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype
Yu et al. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma
Adlakha et al. miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and-independent manner via PUMA-Bak axis
Choe et al. The RUNX2 transcription factor negatively regulates SIRT6 expression to alter glucose metabolism in breast cancer cells
Wang et al. ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer
Abate et al. Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma
Jouret et al. Activation of the Ca2+-sensing receptor induces deposition of tight junction components to the epithelial cell plasma membrane
Kritsch et al. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer
Tang et al. Lapatinib induces p27Kip1-dependent G₁ arrest through both transcriptional and post-translational mechanisms
Sakai et al. The GCN5-CITED2-PKA signalling module controls hepatic glucose metabolism through a cAMP-induced substrate switch
Jiang et al. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells
Yi et al. The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis
Yang et al. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma
Li et al. S100A7 acts as a dual regulator in promoting proliferation and suppressing squamous differentiation through GATA‐3/caspase‐14 pathway in A431 cells
Zhu et al. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway
Intuyod et al. RETRACTED ARTICLE: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
Huang et al. The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer